文献速递慢性静脉疾病

非肿胀麻醉与肿胀麻醉腔内热消融治疗大隐静脉功能不全及静脉曲张的Meta分析

Meta-analysis of nontumescent-based versus tumescent-based endovenous therapies for patients with great saphenous insufficiency and varicose veins.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2018-01-01

本Meta分析检索Cochrane、MEDLINE和Embase等数据库,纳入5项随机或半随机试验,比较非肿胀麻醉与肿胀麻醉腔内热消融治疗大隐静脉功能不全合并静脉曲张的临床效果和手术结局。结果显示非肿胀麻醉组术中疼痛评分更优,但静脉临床严重程度评分、疾病特异性生活质量评分及30天主干消融失败率两组无显著差异。作者认为现有证据总体无差异,需新的随机试验进一步明确非肿胀麻醉疗法的获益,尤其长期结局。

要点

  • 非肿胀麻醉组术中平均疼痛评分优于肿胀麻醉组(效应估计值-0.66)。
  • 两组静脉临床严重程度评分(效应估计值-0.21)和Aberdeen静脉曲张问卷评分(效应估计值0.27)无差异。
  • 30天主干消融失败率两组无显著差异(风险比1.27),亚组分析示新型非肿胀麻醉疗法有改善趋势(风险比0.21)。

核心结论

  • 现有合理质量的临床试验证据显示,肿胀麻醉与非肿胀麻醉腔内热消融在多项结局上总体无差异。
  • 术中平均疼痛评分似乎支持非肿胀麻醉干预。
  • 需要新的随机试验进一步明确非肿胀麻醉疗法的获益,尤其长期结局。

研究设计与样本

  • 研究为Meta分析,检索Cochrane对照试验中心注册库(1950年至2017年1月)、MEDLINE(1946年至2017年1月)和Embase(1950年至2017年1月),无语言或发表状态限制。
  • 同时检索世界卫生组织国际临床试验注册平台和ClinicalTrials.gov,并审查相关文献的参考文献列表。
  • 由两名作者独立筛选文献并采用Cochrane偏倚风险评估工具独立评估偏倚风险,数据采用随机效应模型提取和合并。
  • 文献检索共发现9项研究,其中5项纳入分析。

主要发现

  • 术中平均疼痛评分:非肿胀麻醉组与肿胀麻醉组比较,效应估计值为-0.66,差异显著,支持非肿胀麻醉疗法。
  • 静脉临床严重程度评分:两组效应估计值为-0.21,无差异。
  • Aberdeen静脉曲张问卷评分:两组效应估计值为0.27,无差异。
  • 30天主干消融失败率:两组风险比为1.27,无显著差异。
  • 亚组分析:新型非肿胀麻醉疗法风险比为0.21,旧型非肿胀麻醉疗法风险比为8.6,新型疗法显示出改善趋势。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 需要新的随机试验比较这些治疗方式,以进一步明确非肿胀麻醉疗法的获益,尤其长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to compare the nontumescent-based endovenous therapies with the standard tumescent-based endovenous therapies in regard to clinical effectiveness and procedural outcomes in patients with saphenofemoral incompetence and varicose veins. METHODS: The following databases were searched for studies that were randomized or quasi-randomized trials comparing nontumescent-based endovenous procedures with those requiring tumescence: Cochrane Central Register of Controlled Trials (1950-January 2017), MEDLINE (1946-January 2017), and Embase (1950-January 2017). There were no restrictions based on language or publication status. In the case of ongoing studies, the World Health Organization's International Clinical Trials Registry Platform and the online ClinicalTrials.gov registry were also searched. We also reviewed reference lists of articles relevant to our study to ensure a more complete review. Two authors independently screened and selected studies to be included. These two authors also independently assessed the risk of bias using the Cochrane risk of bias tool. Data were extracted and pooled using a random-effects model. RESULTS: A total of nine studies were found in the literature search, of which five were included in analysis. Four outcomes were reviewed. A significant difference was found between the comparator groups for mean intraprocedural pain score (effect estimate, -0.66), favoring nontumescent-based therapies. There was no difference for Venous Clinical Severity Score (effect estimate, -0.21) for clinical assessment and the Aberdeen Varicose Vein Questionnaire score (effect estimate, 0.27) for the disease-specific quality of life between the groups. The outcome of failure of truncal ablation at 30 days had no significant difference between the groups (risk ratio, 1.27), although a subgroup analysis demonstrated a trend toward improved results with the novel nontumescent-based treatments (risk ratio, 0.21) compared with the old nontumescent-based treatments (risk ratio, 8.6). CONCLUSIONS: Currently available evidence from reasonable-quality clinical trials comparing tumescent-based with non-tumescent-based endovenous therapies shows no overall difference between the groups on a number of outcomes. Mean intraprocedural pain score appears to favor nontumescent-based interventions. Newer randomized trials comparing the treatment modalities are needed to further clarify the benefits of nontumescent-based therapies, particularly with regard to long-term outcomes.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Harlock JA, Elias F, Qadura M, et al. Meta-analysis of nontumescent-based versus tumescent-based endovenous therapies for patients with great saphenous insufficiency and varicose veins. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 30336907. doi:10.1016/j.jvsv.2018.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。